The National Agency for the Control of AIDS has announced that Nigeria is expected to receive a new HIV prevention drug by March 2026 as part of efforts to strengthen the country’s response to HIV transmission.
According to the agency, the development will expand access to modern prevention tools and improve options available to individuals at risk of infection. Officials stated that preparations are underway to ensure proper distribution, regulatory compliance, and integration into existing public health programmes once the drug arrives.
Health authorities described the introduction of the medication as a significant addition to Nigeria’s HIV prevention strategy, complementing existing measures such as awareness campaigns, testing services, and treatment programmes. The rollout is expected to focus on priority populations and regions with higher transmission rates.
NACA emphasized that partnerships with international donors, health institutions, and implementing partners have supported the procurement process. Training for healthcare workers and logistics planning are reportedly being finalized to ensure smooth deployment across approved facilities.
Public health experts say expanding access to preventive medications is critical to reducing new HIV infections and supporting national targets aimed at ending the epidemic as a public health threat. Authorities reaffirmed their commitment to strengthening prevention, treatment, and support systems nationwide.
Post a Comment